Advertisement

i3 Innovus Company Profile

17:04 EDT 23rd May 2013 | BioPortfolio

i3 Research is a full-service CRO therapeutically focused on oncology, central nervous system, and respiratory and infectious diseases. i3 Research provides specialized CRO services in all phases of research, all over the world. Through dedicated therapeutic science — combined with broad capabilities and integrated, scalable services — we help our clients develop better patient care.

Contact

Phone: (866) 322 0959
Email: info@i3global.com


News Articles [ 22 Associated News Articles listed on BioPortfolio]

Biotech rumor mill: Innovus plans on an acquisition

According to a valuable biotech rumor mill, Innovus Pharmaceuticals , a development-stage pharmaceutical company based in San Diego, California, is planning another acquisition to follow this mornin...

Innovus to buy US prescription drugs from Prospector Capital

US-based pharmaceutical company Innovus Pharmaceuticals has entered into an agreement to acquire nine prescription drugs from Prospector Capital Partners II.

[Innovus] gets rights to [Centric Research Institute]'s {Circumserum}

Specialty pharmaco [Innovus Pharmaceuticals Inc.] has licensed worldwide rights (excluding the US) to the [Centric Research Institute]’s (CRI) {Circumserum}.

Innovus financial update

Innovus management update

Nine New Prescription Products for Innovus

Innovus Pharma CEO Interviewed on CEOLIVE.Tv

LA JOLLA, Calif., March 27, 2013 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma") www.innovuspharma.com (OTCBB:INNV) today announced that Dr. Bassam Damaj, Chief Executive Office...

Innovus board of directors update

Drugs and Medications [0 Results]

None

PubMed Articles [ 4 Associated PubMed Articles listed on BioPortfolio]

Gastrointestinal Tolerability and Patterns of Switching in Patients Treated for Primary Osteoporosis: The Swedish Adherence Register Analysis (SARA).

The objective of this study was to describe and analyze the gastrointestinal tolerability and medication switching in patients receiving treatment for primary osteoporosis in Sweden. The study was bas...

Cost-effectiveness of statins revisited: lessons learned about the value of innovation.

BACKGROUND: The economic evaluation of statins has undergone a development from risk-factor-based models to modeling of hard end points in clinical trials with a shift back to risk-factor models after...

Predictors of costs related to cardiovascular disease among patients with atrial fibrillation in five European countries.

Aims To estimate predictors of direct costs and costs of hospitalization related to cardiovascular disease (CVD) in patients with atrial fibrillation (AF) recruited to the Euro Heart Survey on AF (EHS...

Cost of Illness and Drivers of Cost in Atrial Fibrillation in Sweden and Germany.

Background: Atrial fibrillation (AF) is an important public health problem in European countries. AF is associated with increased morbidity and mortality, e.g. from heart failure and thromboembolic ev...

Clinical Trials [0 Results]

None

Companies [ 1 Associated Companies listed on BioPortfolio]

i3 Innovus

i3 Research is a full-service CRO therapeutically focused on oncology, central nervous system, and respiratory and infectious diseases. i3 Research provides specialized CRO services in all phases of r...

More Information about "i3 Innovus" on BioPortfolio

We have published hundreds of i3 Innovus news stories on BioPortfolio along with dozens of i3 Innovus Clinical Trials and PubMed Articles about i3 Innovus for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of i3 Innovus Companies in our database. You can also find out about relevant i3 Innovus Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement